Can anyone explain the reason behind the current price of CANN? It was up around $3.50 in May 2018 with not a heap of news and small revenue. Is it all trump trade wars or is there something that I’m not seeing here? Look like they’re making all the right moves in a very considered approach. Building facility in Echuca, offtake agreement with Aurora, revenue up and big pharma getting hammered for opioid epidemic in the press.
I’m a long term holder struggling to grasp the difference in price from May to now in light of all the great news despite China/US situation. Is the canntrek facility at Shepparton a worry?
would love some more context if anyone has any?
Ann: FY19 Results Confernece Call, page-12
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
